Literature DB >> 16611841

Galanin modulates neuronal and synaptic properties in the rat supraoptic nucleus in a use and state dependent manner.

Michael G Kozoriz1, J Brent Kuzmiski, Michiru Hirasawa, Quentin J Pittman.   

Abstract

The magnocellular neurons of the hypothalamic supraoptic nucleus (SON) synthesize and secrete oxytocin (OXT) and vasopressin (AVP) from their dendrites. These peptides, and several other neurotransmitters, have been shown to modulate afferent glutamatergic neurotransmission in the SON. The neuropeptide, galanin (GAL) is also localized in SON magnocellular neurons and in afferent fibers in the nucleus. We show that GAL dose-dependently reduces evoked excitatory postsynaptic currents (eEPSCs), alters paired pulse ratio and decreases mEPSC frequency, but not amplitude or decay kinetics in both OXT and AVP neurons. GAL therefore modulates excitatory neurotransmission at a likely presynaptic receptor. Neither OXT/AVP, GABA(B) nor cannabinoid antagonists blocked this effect. A GAL2/3 agonist mimicked GAL's action while GAL1 antagonist did not block GAL's effect, suggesting that GAL2/3 receptors mediate the presynaptic effect. In nondehydrated rats GAL causes a small postsynaptic response, as assessed by input resistance measurements. When the rats were water deprived for 2 days the presynaptic response to GAL was unaltered; however, the postsynaptic decrease in input resistance and hyperpolarization was increased, an effect consistent with a previously described increase in GAL1 receptor expression in dehydration. A GAL1 receptor antagonist blocked the postsynaptic effects. Last, when a train of eEPSCs was elicited, GAL was found to inhibit the earlier events in a train but not the latter. This indicates that GAL may modulate a single synaptic event more effectively than trains of synaptic inputs, thereby acting as a high-pass filter.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16611841     DOI: 10.1152/jn.01028.2005

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  8 in total

1.  Depolarization-induced suppression of spontaneous release in the avian midbrain.

Authors:  Mario Alexander Penzo; José Luis Peña
Journal:  J Neurosci       Date:  2011-03-09       Impact factor: 6.167

Review 2.  Effects of galanin on monoaminergic systems and HPA axis: Potential mechanisms underlying the effects of galanin on addiction- and stress-related behaviors.

Authors:  Marina R Picciotto; Christian Brabant; Emily B Einstein; Helen M Kamens; Nichole M Neugebauer
Journal:  Brain Res       Date:  2009-08-20       Impact factor: 3.252

Review 3.  Physiological regulation of magnocellular neurosecretory cell activity: integration of intrinsic, local and afferent mechanisms.

Authors:  C H Brown; J S Bains; M Ludwig; J E Stern
Journal:  J Neuroendocrinol       Date:  2013-08       Impact factor: 3.627

Review 4.  Activity-dependent regulation of synapses by retrograde messengers.

Authors:  Wade G Regehr; Megan R Carey; Aaron R Best
Journal:  Neuron       Date:  2009-07-30       Impact factor: 17.173

Review 5.  Endogenous modulators of synaptic transmission: cannabinoid regulation in the supraoptic nucleus.

Authors:  Neil A McDonald; J Brent Kuzmiski; Nima Naderi; Yannick Schwab; Quentin J Pittman
Journal:  Prog Brain Res       Date:  2008       Impact factor: 2.453

6.  Galanin receptors and ligands.

Authors:  Kristin E B Webling; Johan Runesson; Tamas Bartfai; Ulo Langel
Journal:  Front Endocrinol (Lausanne)       Date:  2012-12-07       Impact factor: 5.555

Review 7.  Somato-dendritic vasopressin and oxytocin secretion in endocrine and autonomic regulation.

Authors:  Colin H Brown; Mike Ludwig; Jeffrey G Tasker; Javier E Stern
Journal:  J Neuroendocrinol       Date:  2020-05-14       Impact factor: 3.870

8.  Information coding in vasopressin neurons--the role of asynchronous bistable burst firing.

Authors:  D J MacGregor; T F Clayton; G Leng
Journal:  Biosystems       Date:  2013-03-14       Impact factor: 1.973

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.